Richard Xie, PhD is a Senior Health Economist at RA Capital. In his current role, Richard is spearheading the effort to communicate investors’ and portfolio companies’ value proposition to payors, policymakers, and society through comprehensive value assessment practices and generalized cost-effectiveness analysis (GCEA) method development. He also serves as Senior Economic and Policy Advisor to No Patient Left Behind, a non-profit committed to lower out-of-pocket costs for patients and preserve incentives for innovation. Prior to joining RA, Richard was Director of Research at the Innovation and Value Initiative (IVI), a non-profit research organization dedicated to advancing methods and practices of health technology assessment. Before IVI, he was a consultant at the Analysis Group, assisting clients in the pharmaceutical industry with their value demonstration efforts at product launches. Richard earned his doctorate in economics from the University of Southern California and his bachelor’s and master’s degrees from New York University.
